Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 3, 2006, Pages 313-319

  Popov, Ivan P ^a   Milicevic, M ^b   Kecmanovic, D ^b   Tomasevic, Z ^a   Radosevic Jelic, Lj ^a   Borojevic, N ^a   Micev, M T ^b   Kezic, I ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Colorectal cancer; Irinotecan; Liver resection; Oxaliplatin

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LEUKOPENIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL;

EID: 33751103680     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adam R., Vinet E.: Regional treatment of metastasis: surgery of colorectal liver metastases. Ann. Oncol. 15 (Suppl 4): iv103-iv106, 2004.
2. Kohne C.H., Folprecht G.: Current perspective in the treatment of metastatic colorectal cancer. Ann. Oncol. 15 (Suppl 4): iv43-iv53, 2004.
3. Therasse P., Arbuck S.G., Eisenhauer E.A., et al.: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 92(3): 205-216, 2000.
4. Fong Y.: Resection of hepatic colorectal metastases: patient selection for treatment. ASCO Educational Book, 695-698, 2003.
5. McCormack P.M., Burt M.E., Bains M.S., et al.: Lung resection for colorectal metastases: 10-year results. Arch. Surg. 127: 1403-14-06, 1992.
6. Minnard E., Fong Y., Weigel T., et al. Surgical resection for hepatic and pulmonary colorectal metastases. Proc Am Soc Clin Oncol 1996; 15: 552.
7. Simmonds P.C., Primrose J.N., Colquitt J.L., Garden O.J., Poston G.J., Rees M.: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Epub ahead of print, British Journal of Cancer advance online publication, doi: 10.1038/sj.bjc.6603033 www.bj-cancer.com, 14 March 2006.
8. McLoughlin J.M., Jensen E.H., Malafa M.: Resection of colorectal liver metastases: current perspectives. Cancer Control 13(1):32-41, 2006.
9. Tomizawa N., Ohwada S., Ogawa T., et al.: Factors affecting the prognosis of anatomical liver resection for liver metastases from colorectal cancer. Hepatogastroenterology 53(67): 89-93, 2006.
10. Shah S.A., Haddad R., Al-Sukhni W., et al.: Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J. Am. Coll. Surg. 202(3):468-475, 2006.
11. Fong Y., Fortner J., Sun R.J. et al.: Clinical score for prediction recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 230: 309-318, 1999.
12. Rodgers M.S., McCall J.L.: Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. Br. J. Surg. 87:1142-1155, 2000.
13. Consolo S., Benedetti M., De Carlo A., et al.: Experience of a peripheral center in the surgical treatment of hepatic metastasis from colorectal cancer. Suppl. Tumori 4(3):S42-43, 2005.
14. Fidler I.J.: Critical factors in the biology of human cancer metastasis: Twenty-eight G.H.A. Clowes Memorial Award Lecture Cancer Res. 50: 6130-6138, 1990.
15. Radinsky R.: Paracrine growth regulation of human colon carcinoma organ-specific metastases. Cancer Metastasis Rev. 12: 345-361, 1993.
16. Long L., Nip J., Brodt P.: Paracrine growth stimulation by hepatocyte-derived insulin-like factor 1: A regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res. 54: 3732-3737, 1994.
17. Radinsky R., Risin S., Fan D., et al.: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res. 1: 19-31, 1995.
18. Singh RK, Tsan R, Radinsky R. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin. Exp. Metastasis 15: 140-150, 1997.
19. Parker C., Roseman B.J., Bucana C.D., et al.: Preferential activation of epidermal growth factor receptor in human colon carcinoma liver metastases growing in nude mice. J. Histochem. Cytochem. 46: 595-602, 1998.
20. Radinsky R., Bucana C.D., Ellis L.M., et al.: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res. 53: 937-943, 1993.
21. Gutman M., Singh R.K., Price J.E., et al.: Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. Invasion Metastasis 14: 362-371, 1995.
22. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 276: 60-66, 1997.
23. Dinney C.P.N., Parker C., Dong Z., et al.: Therapy of human transitional cell carcinoma of the bladder by oral administration of epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide. Clin. Cancer. Res.; 3: 161-168, 1997.
24. Selva E., Raden D.L., Davis R.J.: Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. J. Biol. Chem. 268: 2250-2254, 1993.
25. Chu E., De Vita V.T.: Principles of cancer management: Chemotherapy. In DeVita VT, Hellman S, Rosenberg SA (6th Ed): Cancer principles and practice of oncology. Lippincot Williams & Wilkins, Philadelphia, 349-351, 2001.